ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
2
views
0
references
Top references
cited by
2
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,320
similar
All similar
Record
: found
Abstract
: not found
Book
: not found
Metastatic non-small cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up.
Author(s):
D Planchard
,
S. Popat
,
K Kerr
Publication date:
2020
Read this book at
Bookmark
There is no author summary for this book yet. Authors can add summaries to their books on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Citation Behaviour and Practice
Data availability:
Comments
Comment on this book
Sign in to comment
Similar content
2,320
Treatment with pralsetinib (formerly BLU-667), a potent and selective RET inhibitor, provides rapid clearance of ctDNA in patients with RET-altered non-small cell lung cancer (NSCLC) and medullary thyroid cancer (MTC). Mini Oral Session Presented at: ESMO Asia Congress 2019.
Authors:
DH Lee
,
V Subbiah
,
JF Gainor
The multidisciplinary management of gastro-oesophageal junction tumours. European Society of Digestive Oncology (ESDO): Expert discussion and report from the 16th ESMO World Congress on Gastrointestinal Cancer, Barcelona
Authors:
JL Van Laethem
,
F. CARNEIRO
,
M Ducreux
…
From the ESMO Congress 2019
Authors:
Peter Sidaway
See all similar
Cited by
2
Neoadjuvant osimertinib with/without chemotherapy versus chemotherapy alone for
EGFR
-mutated resectable non-small-cell lung cancer: NeoADAURA
Authors:
Masahiro Tsuboi
,
Walter Weder
,
Carles Escriu
…
Pembrolizumab Plus Chemotherapy for Advanced Non-Small-Cell Lung Cancer Without Tumor Pd-L1 Expression in Asia
Authors:
Ying Cheng
,
James Chih-Hsin Yang
,
Isamu Okamoto
…
See all cited by